TROMBOEMBOLIYa LEGOChNOY ARTERII U PATsIENTA S ZABOLEVANIEM SPEKTRA OPTIKOMIELITA (OBSUZhDENIE KLINIChESKOGO NABLYuDENIYa I OBNOVLENNYKh KLINIChESKIKh REKOMENDATsIY ESC, 2019)

A Yu Emelin; S N Yanishevskiy; Ya B Skiba; R V Andreev; A Yu Polushin; V A Panov; V D Puchek; I M Buchin

doi:10.17816/rmmar26134

Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) :57 -60. DOI: 10.17816/rmmar26134

Articles

research-article

TROMBOEMBOLIYa LEGOChNOY ARTERII U PATsIENTA S ZABOLEVANIEM SPEKTRA OPTIKOMIELITA (OBSUZhDENIE KLINIChESKOGO NABLYuDENIYa I OBNOVLENNYKh KLINIChESKIKh REKOMENDATsIY ESC, 2019)

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

A Yu Emelin, S N Yanishevskiy, Ya B Skiba, R V Andreev, A Yu Polushin, V A Panov, V D Puchek, I M Buchin. TROMBOEMBOLIYa LEGOChNOY ARTERII U PATsIENTA S ZABOLEVANIEM SPEKTRA OPTIKOMIELITA (OBSUZhDENIE KLINIChESKOGO NABLYuDENIYa I OBNOVLENNYKh KLINIChESKIKh REKOMENDATsIY ESC, 2019). Russian Military Medical Academy Reports, 2019, 38(3 (Прил)): 57-60 DOI:10.17816/rmmar26134

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	2019 ESC Guidelines for the diagnosis and management of acute pulmonaryembolism developed in collaboration with the European Respiratory Society (ERS)// European Heart Journal. - 2019. - № 00. - 1-61.

[2]	Anderson F.A. Jr., Spencer F.A. Risk factors for venous thromboembolism// Circulation. - 2003. - № 107. - I9-I16.

[3]	Dada R. Acute jugular vein thrombosis during rituximab administration: Review of the lit // J. Oncol. Pharm. Practice. - 2014. - № - 1-5.

[4]	Dresden S., Mitchell P., Rahimi L. Right ventricular dilatation on bedside echocardiography performed by emergency physicians aids in the diagnosis of pulmonary embolism // Ann. Emerg. Med. - 2014. - № 63. - 1624.

[5]	Freund Y., Cachanado M., Aubry A. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial // JAMA. - 2018. - № 319. - 559-566.

[6]	Kline J.A., Mitchell A.M., Kabrhel C. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism // J. Thromb. Haemost. - 2004. - № 2. - 1247-1255.

[7]	Marti C., John G., Konstantinides S. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and metaanalysis // Eur. Heart J. - 2015. - № 36. - 605-614.

[8]	Meyer G, Vicaut E, Danays T. Fibrinolysis for patients with intermediate-risk pulmonary embolism // N. Engl. J. Med - № 2014. - № 370. - 1402-1411.

[9]	Righini M, Van Es J., Den Exter P.L. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study // JAMA. - № 2014. - № 11(311). - 1117-1124.

[10]	Righini M., Goehring C, Bounameaux H. Effects of age on the performance of common diagnostic tests for pulmonary embolism // Am. J. Med. 2000. - № 109. - 357-361.

[11]	Senkus E., Jassem J. Cardiovascular effects of systemic cancer treatment// Cancer Treat Rev. - 2011. - № 4(37). - 300-311.

[12]	Shichita T., Ito M., Yoshimura A. Post-ischemic inflammation regulates neural damage and protection// Front. Cell. Neurosci. - 2014. - № 14. - 319.

[13]	Yang F., Wang,Z., Wei,X. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke // J. Cereb. Blood Flow Metab. - № 34. - 660-667.

[14]	Young A.M., Marshall A., Thirlwall J. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) // J. Clin. Oncol. - 2018. 3- № 6. - 2017-2023.